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Purpose. One of the great challenges in surgical tendon rupture repair is to minimize peritendinous adhesions. In order to reduce
adhesion formation, a physical barrier was applied to a sutured rabbit Achilles tendon, with two different immobilization protocols
used postoperatively. Methods. Thirty New Zealand white rabbits received a laceration on the Achilles tendon, sutured with a 4-
strand Becker suture, and half of the rabbits got a DegraPol tube at the repair site. While fifteen rabbits had their treated hind leg in
a 180∘ stretched position during 6 weeks (adhesion provoking immobilization), the other fifteen rabbits were recasted with a 150∘
position after 3 weeks (adhesion inhibiting immobilization). Adhesion extent was analysed macroscopically, via ultrasound and
histology. Inflammation was determined histologically. Biomechanical properties were analysed. Results. Application of a DegraPol
tube reduced adhesion formation by approximately 20%—independently of the immobilization protocol. Biomechanical properties
of extracted specimen were not affected by the tube application. There was no serious inflammatory reaction towards the implant
material. Conclusions. Implantation of a DegraPol tube tightly set around a sutured tendon acts as a beneficial physical barrier and
prevents adhesion formation significantly—without affecting the tendon healing process.
1. Introduction
Tendon repair is a field in surgery where improvements are
still welcome. Complications such as scar formation and
adhesion in the tendon sheath in the early healing phase
up to 6 weeks do occur in 7 to 15% of the cases, which
leads to increased work disability and costs [1]. In particular,
there is a need to reduce peritendinous adhesion formation
because this is reported to be themost common complication
following flexor tendon repair in the hand [2]—but also
in the Achilles tendons, functional complications caused
by adhesion are reported [3]. Hence, different antiadhesion
strategies to improve the gliding capability of the regenerating
tendon are being developed [4]. First of all, the postoperative
treatment has to be optimized with respect to its impact on
the adhesion extent as it is well known that for example in
Achilles tendon regeneration the ankle angle plays a crucial
role [5]. Secondly, physical antiadhesion barriers consisting
of biomaterials such as fibronectin [6], collagen [3], or
silk [7] have been reported to show positive effects with
respect to reducing adhesion formation. Finally, antiadhesive
agents were beneficially administered such as 5-fluorouracil
[8], hyaluronic acid, and ADCON-T/N, being a gelatine-
polyglycan ester compound [9] or anti-inflammatory drugs
like ibuprofen [10].
Hence, concepts of adhesion prevention include postop-
erative treatment strategies and pharmacological as well as
mechanical agents. An effective mechanical barrier should
be biocompatible, biodegradable to achieve tissue integration
and prevent buldging. Furthermore, it should be easy in
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surgical handling during implantation and cause only a
low inflammatory response. The polymer DegraPol which
is a copolymer of poly-hydroxy-butyrate and 𝜀-caprolactone
meets all these requirements [11]. It has been shown to be an
ideal scaffold material for tenocytes [12]. In recent studies,
we checked the cellular response toward classic DegraPol
in Achilles tendon repair in a rabbit model (mimicking the
biomechanical properties of human flexor tendons of the
hand) and found no adversary effects [13]. Subsequently, we
synthesized a new more elastic DegraPol polymer in order to
facilitate surgical handling [14].
In the study presented here, an electrospun DegraPol
tube as an antiadhesive was investigated. Therefore, the
adhesion extent of lacerated rabbit Achilles tendons 6 weeks
after surgery either with or without the application of a
DegraPol tube was determined by macroscopic evaluation,
by dynamic ultrasound, and by histology. The rabbit Achilles
tendon is surrounded by a leaflet of fascia and it has similar
biomechanical properties as the human flexor tendons of the
hand [15, 16]. In order to modulate the adhesion in the rabbit
Achilles tendon model, we used two different postoperative
immobilization protocols: the ankle angle of the cast was
changed after 3 weeks from 180∘ to 150∘ (adhesion inhibiting
immobilization protocol) or the cast had an ankle angle of
180∘ for the full 6-week period (adhesion provoking immobi-
lization protocol). Biomechanical properties including load
until failure, cross sectional area (CSA), stiffness, E-modulus,
and failure stress were determined. Additionally, inflamma-
tory reaction was determined based on macrophages and
lymphocytes. Hence, the two hypotheses were that (i) the
application of a DegraPol tube around the repaired tendon
would reduce adhesion formation without an inflammatory
reaction in both postoperative treatment models and (ii) the
biomechanical properties of the regenerated tendons would
not be adversely affected by the implantation of a DegraPol
tube.
2. Materials and Methods
2.1. Block Copolymer DegraPol. A biodegradable polyester
urethane polymer (trade nameDegraPol)with poly-hydroxy-
butyrate as a crystalline segment and 𝜀-caprolactone as a soft
segment was synthesized according to an adapted protocol
[14]. Briefly, for the synthesis of the block copolymer, 25wt%
of poly(3-(R)-hydroxybutyrate)-co-(𝜀-caprolactone)-diol
(𝑀
𝑛
= 2824 gmol−1) and 75wt% with 𝑀
𝑛
= 1000 gmol−1
poly(𝜀-caprolactone)-diol-co-glycolide (15mol% glycolide
85mol% 𝜀-caprolactone) were dissolved in 1.4-dioxane and
dried by heating and refluxing the solvent over molecular
sieves (pore size 0.4 nm). The reaction mixture was cooled
to 83∘C before the stoichiometric amount, with respect
to the two diols, of 2,2,4-trimethylhexane-diisocyanate
(TMDI) was added. After about one day of reaction, three
portions of dibutyltin dilaurate (20 ppm) were added within
1 day in order to reach molecular weight of 110 kDa. The
polymer was precipitated in dry ice cooled hexane isomers
and subsequently purified via dissolution in chloroform
and filtration over a silicagel 60 (Fluka) column. A second
precipitation in cooled ethanol ended the process.
2.2. Scaffold Fabrication and Characteristics. Theelectrospin-
ning setup was assembled in-house and consisted of a syringe
pump (Racel Scientific Instruments Inc., USA), a spinning
head consisting of a central stainless steel tube (1mm inner
diameter and 0.3mm wall thickness, Angst & Pfister AG,
Switzerland), a cylindrical rotating aluminum mandrel for
fiber collection (length: 100mm, diameter: 4mm), and a DC
high voltage supply (Glassman High Voltage Inc., USA). A
25wt% solution of the DegraPol (DP) in chloroform (Fluka,
puriss., Switzerland) was prepared by dissolving the polymer
under stirring overnight. Electrospinning voltage (15 kV) was
applied with a high voltage supply between a needle and the
rotating cylindrical collector (20 cm apart from each other).
As-spun tubes (with randomly oriented fibres) were removed
from the target by slightly swelling them with ethanol (Fluka,
puriss., Switzerland) and then dried under vacuum at room
temperature. In Figure 1(a), the high elasticity of such a tube is
shown.The overall mesh porosity 𝑃was calculated according
to 𝑃 = (1 − 𝜌/𝜌
0
) × 100 (%), where 𝜌 denotes the density
of the electrospun mesh and 𝜌
0
is the bulk density of the
electrospun mesh determined gravimetrically using weights
of precisely cut samples of defined area and thickness; 𝑃
was 75.2 ± 0.4%. The wall thickness was 357.0 ± 17.7 𝜇m as
determined bymeans of scanning electronmicroscopy (SEM,
FEI, Nova NanoSEM 450). The fibres of the electrospun tube
were randomly oriented. The tubes had an inner diameter
of 4mm and were cut into pieces of 1 cm in length. Their
degradation half-lives were determined to be approximately
3 months.
2.3. Animals. For the in vivo study, thirty female New
Zealand white rabbits aged 12 to 16 weeks were used (Charles
River, Research Models and Services, Germany). They were
specific pathogen free (SPF). All animals were housed in pairs
in two interconnected cages, each of them with a bottom
area of 70 cm × 70 cm and a height of 62 cm (Indulab,
Switzerland). The animals were maintained under controlled
conditions: temperature 22 ± 1∘C, 45% relative humidity,
15 air changes per hour, and a light/dark rhythm of 12
hours. The rabbits had free access to water (automatic water
supply), autoclaved hay, and straw ad libitum as well as to
standard pellet diet (Kliba Nafag, Nr. 3410, Provimi Kliba
AG, Switzerland). Ethical approval was obtained for the
experiments from the veterinary office of Zurich, Switzerland
(reference numbers 92/2009 and 193/2012). Prior to surgery,
all animals were acclimatized to their environment for two
weeks.
2.4. Achilles Tendon Repair. Before implantation, the DP
tubes were sterilized with ethylene oxide at 38∘C.The rabbits
received premedicationwith 65mg/kg bodyweight Ketamine
and 4mg/kg Xylazine. A venous catheter was inserted in the
marginal ear vein. The rabbits were intubated with Propofol
i.v. 0.6mg/kg–1.3mg/kg. Anaesthesia was maintained with
1-2% isofluorane. In order to ensure systemic analgesia
during the time of operation, 0.2-0.3mg/kg body weight
Butorphanol (Dr. E. Graeub AG, Berne, Switzerland) was
applied preoperatively. The hind legs were cleaned with
iodine. The Achilles tendon exposure was obtained through
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Figure 1: (a) Very elastic DegraPol tube used for mechanical blockage of regenerating tendon tissue and surrounding tissue, (b) and (c)
implantation of tube in addition to a conventional 4-strand Becker suture, (d) New Zealand white rabbit with a cast having an ankle angle
of 180∘ (fully stretched), (e) extracted tendon specimen with 4-strand suture and (f) extracted tendon specimen with DP tube application in
addition to 4-strand suture.
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a paratendineal incision of cutis, subcutis, and fascia. The
medial and lateral M. gastrocnemius of the Achilles tendon
complex was then sliced perpendicularly to the length of
the tendon 2.0 cm above the calcaneus and the two tendon
stumps were sutured (4-strand Becker suture) using a USP
4.0 polypropylene thread. In case of DP tube application,
one of the two tendon stumps was pulled through the DP
tube before suturing (Figures 1(b) and 1(c)). Subsequently
the wound was closed with a running suture (using a USP
6.0 polypropylene fiber) of the fascia and interrupted skin.
Immediately after surgery, aDuragesicmatrix patch (Janssen-
Cilag AG, Switzerland) was applied with 4.2mg Fentanyl
per patch in order to provide analgesia for about 72 hours
with 25𝜇g/h Fentanyl. Postoperative treatment included a
cast having an angle of 180∘ at the ankle for a total of 12
rabbits (6 with and 6 without tube; adhesion provoking
immobilization) (Figure 1(d)). The cast was well padded and
it was changed after 3 weeks. For the other 12 rabbits, the
cast was also changed after 3 weeks; however, a cast with
a smaller angle of 150∘ was applied (adhesion inhibiting
immobilization). Great attention was paid to make the casts
not too tight so that it was tolerated well by the rabbits (they
did not bite the cast). Six weeks after surgery, the rabbits were
euthanized in deep anaesthesia (100mg/kg Ketamine and
4mg/kg Xylazine) with 80mg/kg Pentobarbital (Esconarkon
ad us. vet., Switzerland).
2.5. Treatment Groups. The thirty rabbits were randomly
distributed into eight groups with 𝑛 = 3 or 6 (Figure 2). All
were operated on one hind leg [17]. The tendons of twenty-
four rabbits were analysed histologically (eighteen of them
for adhesion scoring (twelve in the 180∘/150∘ and six in the
180∘/180∘ group), six for inflammation analysis, all in the
180∘/180∘ group), with groups classified by the application of a
DP tube in addition to a 4-strand Becker suture (application
or no application) and by the casting protocol (ankle angle
change from 180∘ to 150∘ (180∘/150∘ group) or 180∘ for
the full 6-week period with a cast change after 3 weeks
(180∘/180∘ group)). The tendons of six rabbits were analysed
biomechanically, all receiving a 180∘/150∘ immobilization,
including three animals with DP and three without. The
counter legs that were not treated (NT) served as control.
2.6. Rating during Tendon Extraction. Achilles tendons
including flexor digitorum superficialis and surrounding tis-
sue were extracted. During extraction, the extent of adhesion
formation was macroscopically evaluated (carefully paying
attention to not move the tendon in the sheath) and scored
semiquantitatively with 0 = good gliding (no adhesion), 1 =
middle gliding (some adhesion) and 2 = no gliding (maxi-
mum adhesion). The surgeon was blinded to the treatment.
2.7. Dynamic Ultrasound. TheAchilles tendons of all animals
were imaged with high-frequency ultrasound before surgery
and at the end point of the experiments before explanting
the tendons. Ultrasound imaging was performed with an
ultrasound unit (iU22 Ultrasound System, Philips Health-
care, Switzerland) with a linear high-frequency hockey-stick
probe of 17.5MHz (L17-5io BroadbandCompact Linear Array
Transducer, Philips Healthcare, Switzerland). The examina-
tion protocol consisted of a dynamic imaging of the gliding
Achilles tendon by moving the flexor digitorum superficialis
of the rabbit paw. All measurements were done freehand.The
films of the gliding tendons were scoredwith 0 = good gliding
(no adhesion), 1 = middle gliding (some adhesion) and 2 =
no gliding (maximum adhesion) (see Supplementary Videos
1 and 2 (see Supplementary Material available online at
http://dx.doi.org/10.1155/2014/656240)). Colour gain adjust-
ment was calibrated on the counter leg that was not treated
(healthy side).
2.8. Quantification of Adhesion Extent and Inflammation
by Histology. After extraction, the Achilles tendon spec-
imens were immediately frozen at −20∘C. After being
thawed to room temperature, they were dehydrated, paraffin-
embedded, and sectioned into 5 𝜇m thick slices, which
were cross sections in the DP tube region (perpendicular
to the Achilles tendon). After being deparaffinized with
xylene and rehydrating the sections (descending gradient of
ethanol), they were differently stained: Picrosirius red and
H&E according to commonly established procedures.
Picrosirius red stained sections were used to quantify the
adhesion extent at 8xmagnification (Leica EZ4Dmicroscope,
Switzerland). Here, adhesion formation was quantified in
five subsequent cross sections separated by 2.0mm using a
method by Tan et al. [18]. Analysis was done in a blinded
fashion. The percentage of adhesion was calculated by the
length of the contact region of the tendon under view with
the surrounding tissue divided by the total perimeter. The
length of the contact region and the whole perimeter were
determined using synedra View 3 software (version 3. 1. 0. 3.).
Inflammation zones based on macrophages and on lym-
phocytes were evaluated in the H&E-stained sections at 100x
and 200x magnification based on their morphology (5 FOV
of each object, semiquantitative analysis); scores: 1 = healthy
tendon tissue, 2 = some fine films of inflammation, 3 =
more fine films of inflammation, 4 = few zones (areas) of
inflammation, and 5 = many zones (areas) of inflammation.
2.9. Biomechanical Tests. Before measurement at room tem-
perature (21∘C), the tendons were thawed overnight at 4∘C.
All tendons were harvested from the hind legs including the
muscle and the calcaneus. On the muscle side, the samples
were mounted in serrated clamps after being wrapped in two
pieces of cloth to reduce slippage [19], and on the bone side,
a device fixing the calcaneus in a rectangular position to the
tendon was used. All samples were tested in uniaxial tension
to failure at 1mmmin−1 speed on a Zwick 1456 tensile testing
machine (1 kN load-cell, 0.1 𝜇m extensiometer, TestXpert 10,
Germany) with preconditioning (10 cycles to 10N). The
samples were sprayed with phosphate buffered saline during
measurement in order to prevent drying. Load until failure
(N) was determined as the maximum load measured.
The CSA was determined 2.0 cm above the calcaneus by
a custom designed linear laser scanner adapted by Vergari et
al. with 𝑛 = 6 per specimen before tensile testing [20, 21].
The load until failure (N) was divided by the thus-determined
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Figure 2: Experimental design depicting number of rabbits used for the corresponding surgical and postoperative treatments. Accordingly,
the three different analysis approaches are given (adhesion = determination of adhesion extent by macroscopic, dynamic ultrasound and
histological analyses; biomechanics = determination of load until failure, cross-sectional area, stiffness, failure stress and elastic modulus;
inflammation = determination of macrophage and lymphocyte density). Moreover, links to figure numbers of the respective results are given.
CSA at the repair site (m2) resulting in the failure stress at
the repair site (Pa).The elastic modulus (E-Modulus; Pa) was
determined in the stress-strain curves.Moreover, the stiffness
(N/mm) was determined in the force-elongation curves.
2.10. Statistical Analysis. Histomorphometric and biome-
chanical data were analysed with StatView 5.0.1. One-way
analysis of variance (one-way ANOVA) was conducted.
Pairwise comparison probabilities (𝑃) were calculated using
Fisher’s PLSD. 𝑃 values <0.05 were considered significant.
Values were expressed as means ± standard deviations.
3. Results
3.1. Adhesion Provoking and Adhesion Inhibiting Immobiliza-
tion. The two different postoperative casting protocols had
a significant impact on the adhesion extent. A change of
the ankle angle from 180∘ to 150∘ after 3 weeks reduced the
adhesion extent significantly from 82.7 ± 9.7% to 31.9 ± 9.8%
(𝑃 < 0.05) when the tendon laceration was repaired by a
conventional 4-strand Becker suture (Supplementary Table
1). Accordingly, in the tube-treated group, the change of the
ankle angle after 3 weeks leads to a reduction in the adhesion
extent from 69.3 ± 9.8% to 15.6 ± 10.9% (𝑃 < 0.05).
3.2. Impact of DegraPol Tube on Adhesion. The extent of
adhesion formation was independently evaluated by two
different persons using a semiquantitative scoring system by
macroscopic observation during extraction (MC) and by the
percentage of contact regions of the Achilles tendon to its
surrounding tissue calculated from five subsequent histolog-
ical cross-sections (GMB) (Figure 3).There was a statistically
significant difference in adhesion formation between tube-
treated specimen and specimen without tube. The implanta-
tion of a DP tube reduced the contact area to the surrounding
tissue significantly from 31.9 ± 9.8% to 15.6 ± 10.9% in
adhesion inhibiting postoperative model (𝑃 < 0.05), while
it reduced the contact area from 82.7 ± 9.7% to 69.3 ± 9.8% in
the adhesion provoking postoperative model (𝑃 < 0.05).
3.3. Biomechanics. Figure 4 shows the biomechanical results
for rabbits with the 180∘/150∘ casting regime (adhesion
inhibiting model). There were no statistical significant differ-
ences between the DP treated and the mere 4-strand treated
specimen (neither for load until failure (𝑃 = 0.81) nor for
CSA (𝑃 = 0.13), for stiffness (0.44), for E-Modulus (0.20),
and for failure stress (0.72)), indicating no adverse effect of
the polymer tube on biomechanical properties of the healing
tendon.
3.4. Correlation of Macroscopic and Histological Evaluation.
Semiquantitative adhesion scores gathered immediately after
tendon extraction were correlated to the quantitative analysis
of adhesion determined in histological sections (Figure 5(a)).
A positive correlation was found (𝑟2 = 0.86).
3.5. Correlation of Dynamic Ultrasound and Histological
Evaluation. Semiquantitative adhesion scores from dynamic
ultrasound were correlated with the quantitative analysis of
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FDS
1000 𝜇m
Figure 3: Picrosirius red stained 5 𝜇mhistological sections of the three groups considered at 8x magnification.Key: 4-strand +DP = 4-strand
Becker suture and application ofDegraPol tube; 4-strand = 4-strand Becker suture; no treatment = control groupwithout any intervention;DP
= DegraPol, AT = Achilles tendon; FDS = Flexor digitorum superficialis. The black lines in the lower figures denote the whole circumference,
while the green lines depict the adhesion formation.
adhesion determined in histological sections (Figure 5(b)). A
positive correlation was found (𝑟2 = 0.79).
3.6. Inflammation. Inflammation was semiquantitatively
scored and found to be not significantly different whether a
DP tube was implanted or not for macrophages (Figure 6(a));
only lymphocyte analysis showed a significant higher cell
density for the DP treated specimen (𝑃 = 0.05) (Figure 6(b)).
4. Discussion
The most common problem arising during tendon healing
is the formation of fibrous adhesions to the surrounding
tissue [2]. The etiology is based on the destruction of a
cell-retentive layer (basement membrane) on the tendon
surface. At the site of the tendon rupture, cells exit from
the damaged tendons where the basement membrane is
damaged [22].Thus, adhesions are mostly evoked by scarring
between two damaged surfaces [23]. Many studies dealing
with the application of lubricants have been published [18,
24–26]—the outcomebeing controversial. For example, while
some authors claim a beneficial effect of hyaluronic acid
(based on adhesion scoring and cell density) [27], others
found adhesion to be unaffected [28]. Physical barriers such
as collagen membranes [3], PGA membranes [29], PLGA
membranes [10], or spontaneously forming hydrogels [30]
positively affected adhesion formation, although their use
in the clinical set up is still very scarce due to limited
tissue integration, inflammatory reactions, cell stress caused
by lowered pH, or decreasing reduced final strength of the
regenerated tendon.
Different rehabilitation protocols are reported to have an
impact on the clinical outcome of tendon rupture repairs.
Early active motion protocols go along with lower compli-
cation rates [31]. In an experimental study by Pihlajama¨ki et
al., the cellular composition at the repair site 6 weeks after
surgery of the healing rabbit Achilles tendon was similar
whether a cast was applied or not [29]. In contrast, other
studies denote the importance of the specific postoperative
casting regime [32]. Besides the length of the application
period of the cast, the ankle angle is one important parameter
[5].
With the intention to drastically modulate the adhesion
extent, we used two different postoperative immobilization
protocols. The ankle angle of the cast was either changed or
not 3 weeks after surgery. Early active or passive motion was
not included—in contrast to other studies [33, 34], because
a defined and standardized early motion protocol is very
difficult to realize in rabbits.Therefore, a cast was applied for a
total time period of 6 weeks (end of experiments). While one
group received the whole 6 weeks a 180∘ cast (renewed after
3 weeks, provoking adhesion formation), the other group
had a 180∘ cast for the first 3-week period and then a new
150∘ cast for the second 3-week period (inhibiting adhesion
formation). A totally stretched position was chosen because
the Achilles tendon is perfectly relaxed and the rabbit’s foot is
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Figure 4: Load until failure (a), CSA (b), stiffness (c), failure stress (d), and E-modulus (e) determined for the tendons of rabbits with a
180∘/150∘ casting regime. Key: NT = no treatment (contralateral legs); DP = 4-strand Becker suture and a DegraPol tube; 4-strand = 4-strand
Becker suture. 𝑃 values <0.05 are marked by asterisk (∗). Sample size was 𝑛 = 3 for DP and 4-strand groups, respectively, and 𝑛 = 6 for NT
group.
in a position which is usually taken during rest.The adhesion
inhibiting protocol including a change in the ankle angle
led to a clear reduction of adhesion by over 50%, not only
because some initial fibrous adhesion were decreased by the
intervention of a positional change among the involved tissue
layers, but also by having the angle a little bit closer to angles
occurring during jumping [35].
Mechanical blockage by an electrospun DegraPol
polymer tube 6 weeks after surgery was tested in both
postoperative treatment models and the adhesion provoking
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during 6 weeks (cast renewed after 3 weeks). Sample size was 𝑛 = 3 for 180∘/180∘, 𝑛 = 6 for 180∘/150∘ group, and 𝑛 = 18 for NT group.
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Figure 6: Semiquantitative evaluations of macrophages (a) and lymphocytes (b) in the tendon tissue. Scores: 1 = healthy tendon tissue, 2
= some fine films of inflammation, 3 = more fine films of inflammation, 4 = few zones (areas) of inflammation, 5 = many zones (areas) of
inflammation. Sample size was 𝑛 = 3 for all groups; except for NT group (𝑛 = 6).
as well as the adhesion inhibiting model. We had tested
DegraPol before with respect to its cell response in vivo
12 weeks after operation [13]. The polymer DegraPol is a
biocompatible and totally biodegradable block copolymer.
With its hard and soft segments that can be varied user-
defined in weight ratios during production, it allows a wide
range of degradation half-lives, stabilities, and biomechanical
characteristics. Originally, it was developed as a scaffold
material for bone reconstruction [36]. However, DegraPol
was also shown to be a good scaffold for tenocytes [37]. Even
after having changed its synthesis protocol in order to make
the polymer more elastic to facilitate the surgeon’s pulling it
over the repair site, no adverse cellular effects 12 weeks after
operation were observed upon implantation [14]. The very
high elasticity of the electrospun DegraPol mesh denoted by
an elongation at break of 544 ± 68% is a big advantage over
other mechanical barrier options—even the best ones with
respect to this property—such as electrospun PLGA having
BioMed Research International 9
an elongation at break of “only” 324 ± 78% [38]. Moreover,
degrading DegraPol is pH-neutral while other polymers
used as implant materials degrade with lowering the pH (like
PLGA).
In this study, the quantitative determination of the
adhesion extent by histological analysis clearly showed that
the implantation of a DegraPol tube around the conven-
tionally sutured tendon reduced the peritendinous adhesion
significantly by around 20%—independent of the postop-
erative treatment mode. Moreover, this antiadhesive effect
was clearly supported by our semiquantitative findings based
on macroscopic inspection and evaluation and scoring of
the gliding capacity by dynamic ultrasound, both correlating
positively to the histological findings. Although other studies
report much higher reduction of adhesion extent up to
88% by using, for example, an Fe3+ crosslinked carboxy-
methylcellulose barrier, such results are not directly com-
parable to our findings because the adhesion extent was
determined at a different time point—already after 2 weeks
[39], when peritendinous adhesion formation is not yet
completed [40]. Importantly, the implantation of our electro-
spun DP tube did not lead to a decrease in failure strength
nor in other biomechanical parameters such failure stress,
tensile modulus, or stiffness—standing in contrast to other
studies using, for example, cortisone as antiadhesive that
leads to great problems caused by decreased biomechanical
properties after implantation [41].
Though not statistically significantly different, the failure
stress and the E-Modulus—two typical material properties
[42]—of the DP tube specimen were approximately 30%
lower compared to no-tube specimen; this is mainly caused
by the approximately 30% larger CSA provoked by the DP
tube that is not yet degraded fully after 6 weeks. In addition,
inflammatory reaction to the implant material was only
found to be marginally increased for lymphocytes, but not
for macrophages which was the abundant subpopulation of
inflammatory cells, and which might cause problems when
materials that are less biocompatible such as cellulose [43] are
used as physical barriers.
Although adhesion formation was analyzed by macro-
scopic evaluation, dynamic ultrasound, and quantitative his-
tology, it might be favorable in future studies to quantify
the gliding capability of the rabbit Achilles tendon by range-
of-motion analysis [44]. Moreover, inflammatory reactions
towards the implant material might be analyzed in more
details using immunohistochemistry methods [45].
5. Conclusion
In summary, we could demonstrate that an electrospun
DegraPol tube acts as an efficient physical barrier enabling
a reduction of peritendinous adhesion without changing
biomechanical characteristics and not affecting inflamma-
tion—and regardless of the postoperative treatment protocol.
In both treatment models, we found a significant adhesion
reduction of approximately 20%. The beneficial impact of
this electrospun material could be clearly demonstrated for
this purpose. Thus, peritendinous adhesion prevention by a
DegraPol tube is a promising approach and may find its way
to clinical application after some further modifications will
be undertaken; therefore, we plan to load such a tube with
tendon growth factors inside in order to accelerate tendon
healing, thus generating a device that is physically blocking
adhesion formation outside, while simultaneously promoting
the healing process inside.
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